cefixime and zithromax

cefixime has been researched along with zithromax in 97 studies

Research

Studies (97)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (11.34)18.2507
2000's19 (19.59)29.6817
2010's40 (41.24)24.3611
2020's27 (27.84)2.80

Authors

AuthorsStudies
Vartiovaara, I1
Klepser, ME; Nightingale, CH; Quintiliani, R1
Parent, M1
Rodriguez, WJ; Wiedermann, BL1
Mann, RD; Pearce, GL; Wilton, LV1
Kohl, PK; Kratofiel, M; Petzoldt, D; Tu, Y1
Berkley, S; Brookmeyer, R; Gray, RH; Kelly, R; Kiwanuka, N; Li, C; Lutalo, T; McNairn, D; Nalugoda, F; Paxton, L; Quinn, TC; Serwadda, D; Sewankambo, NK; Wabwire-Mangen, F; Wawer, MJ1
Arcidiacono, MM; Demartini, G; Dugnani, S; Fraschini, F; Pintucci, JP; Scaglione, F1
Kamath, R1
Chiu, CH; Lin, TY; Ou, JT1
Angelilli, ML; Matsui, DM; Rieder, MJ; Toscani, M1
Eagan, L1
Abramowsky, C; Gray, RH; Kigozi, G; Meehan, M; Moulton, LH; O'Brien, KL; Quinn, TC; Robb, M; Serwadda, D; Sewankambo, NK; Wabwire-Mangen, F; Wawer, MJ1
Amores, R; Calvo, A; Prieto, J; Sevillano, D; Valero, E1
Arbo, A; Basualdo, W1
Rush, C; Simon, MW1
Cohen, DA; Farley, TA; Johnson, G; Kahn, RH; Lolis, S; Martin, DH1
Clark, A; Golden, MR; Handsfield, HH; Helmers, JR; Hogben, M; Holmes, KK; Hughes, JP; Malinski, C; Stamm, WE; Thomas, KK; Whittington, WL1
Barlam, TF1
Ellen, JM; Trent, M; Walker, A1
Asbel, LE; Goldberg, M; Newbern, EC; Salmon, M; Spain, CV1
Furuya, R; Iyoda, T; Kanayama, A; Kobayashi, I; Matsuzaki, K; Nakayama, H; Saika, T; Tanaka, M; Tatewaki, M1
Egawa, S; Endo, K; Hosobe, T; Kiyota, H; Kobayashi, I; Onodera, S; Suzuki, H; Takahashi, T1
De Vecchi, E; Drago, L; Nicola, L; Zucchetti, E1
Bachiller Luque, MR; Eiros Bouza, JM; Pastor García, E; Vázquez Fernández, ME; Vázquez Fernández, MJ1
Ellis, B; Phillip, S; Sathia, L; Smith, A; Winston, A1
Brill, JR1
Deguchi, T; Maeda, S; Nakane, K; Yasuda, M1
Alexander, S; Evans, J; Hussey, J; Ison, CA; Sankar, KN1
Cole, MJ; Ison, CA; Pereira, R1
Adelson, ME; Balashov, S; Gygax, SE; Mordechai, E1
Maldonado, NG; Takhar, SS1
Dorin, M; Kawahata, T; Morita-Ishihara, T; Nakayama, S; Ohnishi, M; Shimuta, K; Unemo, M1
Drews, SJ; Gratrix, J; Lovgren, M; Martin, I; Read, R; Romanowski, B; Singh, AE; Sutherland, K; Talbot, J1
Giannattasio, A; Giugliano, B; Giuliano, P; Iannaccone, VL; Mastrantonio, P; Pisani, F; Tartaglia, E; Ucciferri, C1
Bergman, J; Drews, SJ; Egan, C; Gratrix, J; Read, R; Singh, AE1
Alam, A; Ashraf, L; Hoffman, IF; Kelly, R; McCormick, DF; Menezes, P; Miller, WC; Neilsen, GA; Rahman, M; Zadrozny, S1
de Melo Oliveira, MD; Hauser, P; Kovari, H; Läuchli, S; Meyer, J; Weber, R; Zbinden, R1
Dillon, JA; Horsman, GB; Levett, PN; Thakur, SD1
Endimiani, A; Furrer, H; Guilarte, YN; Hauser, C; Hirzberger, L; Lupo, A; Selvini, S; Tinguely, R1
Barbee, LA1
Furubayashi, K; Kawahata, T; Morita-Ishihara, T; Nakayama, S; Ohnishi, M; Shimuta, K; Unemo, M1
Antonetti, R; Bonanno, C; Busetti, M; Carannante, A; Cava, MC; Cusini, M; D'Antuono, A; Dal Conte, I; Gaino, M; Ghisetti, V; Giraldi, C; Impara, G; Latino, MA; Matteelli, A; Mencacci, A; Prignano, G; Renna, G; Stefanelli, P; Vocale, C1
Ahmed, MS; Ahsan, MM; Akhtaruzzaman, M; Begum, B; Choudhury, AM; Haque, MA; Hasan, MM; Hossain, MA; Islam, MN; Khaleque, MA; Khan, AH; Khatun, AA1
Chisholm, SA; Cole, MJ; Hoffmann, S; Ison, CA; Spiteri, G; Unemo, M; Van de Laar, M1
Amato-Gauci, AJ; Chisholm, SA; Cole, MJ; Hoffmann, S; Ison, CA; Spiteri, G; Town, K; Unemo, M; van de Laar, M1
Akiyama, K; Arakawa, S; Chokyu, H; Egawa, S; Fujisawa, M; Hamasuna, R; Hanaki, H; Hayami, H; Hirayama, H; Hosobe, T; Imai, T; Ishikawa, K; Ito, K; Ito, M; Ito, S; Iwata, S; Kadena, H; Kadota, J; Kaji, S; Kaku, M; Kano, M; Kawahara, M; Kawai, S; Kiyota, H; Kobayashi, K; Kumon, H; Kuroiwa, K; Maeda, S; Matsubara, A; Matsumoto, T; Matsumura, M; Minamitani, S; Monden, K; Naito, S; Narita, H; Nishi, S; Nishimura, H; Sato, J; Shirane, T; Sumii, T; Sunakawa, K; Takahashi, S; Takayama, K; Tanaka, K; Tsukamoto, T; Uehara, S; Uno, S; Watanabe, A; Yamaguchi, T; Yamamoto, S; Yasuda, M; Yoh, M; Yoshioka, M1
Cole, M; Fredlund, H; Jacobsson, S; Ringlander, J; Unemo, M; Wiggins, C1
McIntyre, JA; Peters, RP; Schaftenaar, E; Verweij, SP1
Brunner, A; Jeney, C; Karpati, S; Marschalko, M; Nemes-Nikodem, E; Ostorhazi, E; Szabo, D1
Cole, K; Cole, MJ; Crook, DW; De Silva, D; Demczuk, W; Eyre, DW; Grad, YH; Martin, I; Mulvey, MR; Paul, J; Peters, J; Peto, TEA; Walker, AS1
Althaus, CL; Desilvestro, V; Foerster, S; Hathaway, LJ; Unemo, M1
Chakanyuka Musanhu, C; Gudza-Mugabe, M; Gwanzura, L; Latif, AS; Machiha, A; Ndowa, F; Shukusho, FD; Tarupiwa, A; Unemo, M; Wi, T1
Amato-Gauci, AJ; Cole, MJ; Jacobsson, S; Spiteri, G; Tripodo, F; Unemo, M; Woodford, N1
Dillon, JR; Horsman, GB; Levett, PN; Thakur, SD1
Glennen, A; Hagan, C; Iwen, PC; Lee, LV; O'Connor, NP; Papp, JR; Razeq, JH; Rowlinson, MC; Ware, D; Wholehan, J1
Bremer, V; Buder, S; Dudareva, S; Guhl, E; Jansen, K; Kohl, PK; Loenenbach, A; Nikisins, S; Sailer, A1
Antony, ML; Chilongola, JO; Horumpende, PG; Mmbaga, BT; Mshana, SE; Mwanziva, CE; Shao, ER; Sonda, TB; Tenu, FF; van Zwetselaar, M1
Amato-Gauci, AJ; Cole, MJ; Day, MJ; Jacobsson, S; Spiteri, G; Unemo, M; Woodford, N1
Deng, X; Klausner, JD1
Majewska, A; Majewski, S; Malejczyk, M; Młynarczyk, G; Młynarczyk-Bonikowska, B1
Amato-Gauci, AJ; Cole, MJ; Day, M; Jacobsson, S; Quinten, C; Spiteri, G; Unemo, M; Woodford, N1
Acharya, B; Arjyal, A; Karki, M; Marasini, B; Pokharel, S1
Choi, SW; Choi, Y; Kim, S; Lee, DH; Lee, HR; Lee, JM; Park, HK; Park, HS; Rho, M1
Dobre-Buonya, O; Kilic, A; McNeil, CJ; Palavecino, EL; Schmerer, MW; Toler, C1
Buder, S; Dudareva, S; Eckardt, M; Gassowski, M; Graeber, I; Guhl, E; Heuer, D; Jansen, K; Selb, R; Tamminga, T1
Cole, MJ; Day, M; Jacobsson, S; Spiteri, G; Unemo, M1
Ahmed, SM; Amin, MR; Das, SK; Hasan, MJ; Islam, MR; Kabir, A1
Abbai, NS; Maise, HC; Naicker, M; Oree, G; Ramsuran, V; Tinarwo, P1
Abe, S; Amarasiri, M; Badavath, VN; Chantaravisoot, N; Chatsuwan, T; Higgins, PG; Hongsing, P; Hurst, C; Jenjaroenpun, P; Kerr, SJ; Kueakulpattana, N; Luk-In, S; Phattharapornjaroen, P; Saethang, T; Shein, AMS; Teeratakulpisan, N; Wannigama, DL; Wongsurawat, T1
Bonongwe, N; Chen, JS; Chikaonda, T; Cohen, MS; Golparian, D; Hobbs, MM; Hoffman, IF; Jere, E; Kamtambe, B; Krysiak, R; Massa, C; Mathiya, E; Matoga, M; Ndalama, B; Unemo, M1
Cai, C; Cao, W; Chen, H; Guo, C; Li, M; Liao, Y; Lin, X; Liu, X; Pei, J; Qin, X; Tang, S; Wang, F; Wu, S; Wu, X; Wu, Z; Xie, Q; Yu, Y; Zheng, H1
Cole, MJ; Dillon, JR; Eremin, S; Escher, M; Galarza, P; Galas, M; Lahra, MM; Martin, I; Ndowa, F; Ramon-Pardo, P; Unemo, M; Weinstock, H; Wi, T1
Aanensen, DM; Abudahab, K; Bluemel, B; Cole, MJ; Day, M; Golparian, D; Jacobsson, S; Sajedi, N; Sánchez-Busó, L; Spiteri, G; Underwood, A; Unemo, M; Yeats, CA1
Amato-Gauci, AJ; Blumel, B; Cole, MJ; Day, MJ; Jacobsson, S; Kulishev, C; Sajedi, N; Spiteri, G; Unemo, M; van der Werf, MJ; Woodford, N1
Barrios-Cárdenas, YJ; Benites, C; Jorge-Berrocal, A; Mayta-Barrios, M; Melano, RG; Salazar-Quispe, F; Vargas-Herrera, N; Yagui, M1
Jenjaroenpun, P; Nitayanon, P; Nokchan, N; Tribuddharat, C; Wongsurawat, T1
Kowalewski, C; Krolak-Ulinska, A; Marusza, W; Mlynarczyk-Bonikowska, B1
Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N1
Cao, W; Dong, Y; Gu, W; Hu, L; Huang, J; Li, Y; Peng, J; Wang, L; Wang, Y; Xiu, L; Yong, G1
Ahmad, M; Shah, N; Siddiqui, MA1
Jain, SH; Lee, CY; Li, JW; Lin, HH; Lin, SY; Lu, PL; Yang, TY1
Allen, H; Althaus, CL; Cole, MJ; Grad, YH; Heijne, JCM; Low, N; Riou, J; Unemo, M1
Chen, W; Li, R; Lin, X; Liu, X; Luo, X; Tang, Y; Zhuang, P1
Blouin, K; Defay, F; Ezin Aloffan, LND; Labbé, AC; Lefebvre, B; Perrault Sullivan, G; Trudelle, A1
Chokyu, H; Fujita, R; Hamasuna, R; Hanaki, H; Hara, M; Hatano, K; Hayami, H; Hayashi, K; Hirayama, H; Hiyama, Y; Hosobe, T; Ihara, H; Inokuchi, J; Ishikawa, K; Ito, K; Ito, M; Ito, S; Izumitani, M; Kadena, H; Kaji, S; Kano, M; Kawahara, M; Kawai, S; Kimura, T; Kiyota, H; Kobayashi, K; Kurimura, Y; Maruyama, T; Masumori, N; Matsumoto, K; Matsumoto, M; Matsumoto, T; Matsumura, M; Miyazaki, J; Monden, K; Naito, K; Nishi, S; Nishimura, H; Nishiyama, H; Sadahira, T; Sato, J; Shiono, Y; Sumii, T; Takahashi, S; Takayama, K; Tanaka, K; Togo, Y; Tojo, T; Uno, S; Wada, K; Yamada, H; Yamamoto, S; Yasuda, M; Yoh, M; Yokoyama, T; Yotsuyanagi, H1
Dingle, TC; Ferrato, C; Gratrix, J; Ma, A; Martin, I; Smyczek, P1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Allen, VG; Farrell, DJ; Lo, S; Low, DE; Melano, RG; Perusini, SJ; Rebbapragada, A; Tan, J; Tijet, N; Towns, L1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

9 review(s) available for cefixime and zithromax

ArticleYear
Treatment of uncomplicated infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae.
    Connecticut medicine, 1994, Volume: 58, Issue:8

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Chlamydia Infections; Chlamydia trachomatis; Female; Gonorrhea; Humans; Male; Research Design; Sexually Transmitted Diseases, Bacterial

1994
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
    Advances in pediatric infectious diseases, 1994, Volume: 9

    Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans

1994
Gonorrhoea: single-dose oral treatment.
    Current problems in dermatology, 1996, Volume: 24

    Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Gonorrhea; Humans; Penicillinase

1996
Emergence and spread of drug resistant Neisseria gonorrhoeae.
    The Journal of urology, 2010, Volume: 184, Issue:3

    Topics: Azithromycin; Cefixime; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Neisseria gonorrhoeae; Population Surveillance; Urethritis

2010
Preparing for an era of untreatable gonorrhea.
    Current opinion in infectious diseases, 2014, Volume: 27, Issue:3

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Drug Administration Schedule; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharynx; Population Surveillance; Practice Guidelines as Topic; Public Health; Treatment Failure

2014
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.
    Medical microbiology and immunology, 2020, Volume: 209, Issue:2

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Europe; Genotype; Gonorrhea; Humans; Neisseria gonorrhoeae; Penicillins

2020
Molecular Mechanisms of Drug Resistance and Epidemiology of Multidrug-Resistant Variants of
    International journal of molecular sciences, 2022, Sep-10, Volume: 23, Issue:18

    Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Cefixime; Ceftriaxone; Drug Resistance; Drug Resistance, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Neisseria gonorrhoeae; Penicillinase; Penicillins; Peptidyl Transferases

2022
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
    The Cochrane database of systematic reviews, 2022, 11-24, Volume: 11

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Chloramphenicol; Ciprofloxacin; Fluoroquinolones; Humans; Monobactams; Ofloxacin; Pakistan; Paratyphoid Fever; Recurrence; Typhoid Fever

2022
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

12 trial(s) available for cefixime and zithromax

ArticleYear
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda.
    AIDS (London, England), 1998, Jul-09, Volume: 12, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxacin; Female; HIV-1; Humans; Incidence; Injections, Intramuscular; Male; Metronidazole; Middle Aged; Penicillin G Benzathine; Prevalence; Sexual Behavior; Sexually Transmitted Diseases; Single-Blind Method; Uganda

1998
Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin.
    British journal of clinical pharmacology, 1999, Volume: 47, Issue:3

    Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Child; Exudates and Transudates; Female; Humans; Male; Otitis Media with Effusion; Time Factors

1999
A clinical trial comparing oral azithromycin, cefixime and no antibiotics in the treatment of acute uncomplicated Salmonella enteritis in children.
    Journal of paediatrics and child health, 1999, Volume: 35, Issue:4

    Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Cephalosporins; Enteritis; Female; Humans; Infant; Male; Prospective Studies; Salmonella Infections

1999
Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda.
    American journal of obstetrics and gynecology, 2001, Volume: 185, Issue:5

    Topics: Azithromycin; Birth Weight; Cefixime; Drug Therapy, Combination; Endophthalmitis; Female; Folic Acid; HIV Infections; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Iron; Metronidazole; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases; Uganda

2001
Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:4

    Topics: Azithromycin; Cefixime; Chi-Square Distribution; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysentery, Bacillary; Feces; Female; Follow-Up Studies; Humans; Infant; Male; Paraguay; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Shigella; Treatment Outcome

2003
The effect of amoxicillin-clavulanate, cefixime and azithromycin on normal throat flora in children with group A streptococcal pharyngitis.
    Clinical pediatrics, 2003, Volume: 42, Issue:5

    Topics: Amoxicillin-Potassium Clavulanate Combination; Azithromycin; Cefixime; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Nasopharynx; Pharyngitis; Prospective Studies; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome

2003
The acceptability and behavioral effects of antibiotic prophylaxis for syphilis prevention.
    Sexually transmitted diseases, 2003, Volume: 30, Issue:11

    Topics: Adolescent; Adult; Antibiotic Prophylaxis; Azithromycin; Cefixime; Cohort Studies; Drug Administration Schedule; Female; Humans; Louisiana; Male; Middle Aged; Patient Satisfaction; Penicillin G Benzathine; Prospective Studies; Risk-Taking; Sexual Behavior; Syphilis; Treatment Outcome

2003
Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.
    The New England journal of medicine, 2005, Feb-17, Volume: 352, Issue:7

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Chlamydia Infections; Contact Tracing; Drug Therapy, Combination; Female; Follow-Up Studies; Gonorrhea; Heterosexuality; Humans; Male; Multivariate Analysis; Patient Compliance; Recurrence; Risk Factors; Sexual Partners

2005
Vulvo-vaginitis in prepubertal girls: new ways of administering old drugs.
    Journal of pediatric and adolescent gynecology, 2013, Volume: 26, Issue:5

    Topics: Administration, Oral; Administration, Topical; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefixime; Child; Female; Humans; Netilmicin; Recurrence; Vulvovaginitis

2013
Prevention and control of sexually transmissible infections among hotel-based female sex workers in Dhaka, Bangladesh.
    Sexual health, 2013, Volume: 10, Issue:6

    Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bangladesh; Candidiasis, Vulvovaginal; Cefixime; Chlamydia Infections; Chlamydia trachomatis; Combined Modality Therapy; Condoms; Cross-Sectional Studies; Developing Countries; Drug Therapy, Combination; Female; Gonorrhea; Health Education; Humans; Incidence; Mass Screening; Metronidazole; Occupational Diseases; Sex Workers; Sexually Transmitted Diseases; Trichomonas Vaginitis; Uterine Cervicitis; Utilization Review; Vaginitis; Vaginosis, Bacterial; Workplace; Young Adult

2013
Comparison between azithromycin and cefixime in the treatment of typhoid fever in children.
    Mymensingh medical journal : MMJ, 2014, Volume: 23, Issue:3

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Child; Child, Preschool; Female; Humans; Male; Typhoid Fever

2014
Open Label Randomized Controlled Comparison of Three Alternative Regimes of Ciprofloxacin, Azithromycin and Cefixime for Treatment of Uncomplicated Typhoid Fever in Bangladesh.
    Mymensingh medical journal : MMJ, 2021, Volume: 30, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Cefixime; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Salmonella typhi; Typhoid Fever

2021

Other Studies

76 other study(ies) available for cefixime and zithromax

ArticleYear
Living with Lyme.
    Lancet (London, England), 1995, Apr-01, Volume: 345, Issue:8953

    Topics: Adaptation, Psychological; Adult; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Finland; History, 20th Century; Humans; Lyme Disease; Male

1995
[Initial empiric treatment of pneumonia and the new antibiotics].
    L'union medicale du Canada, 1994, Volume: 123, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefuroxime; Clarithromycin; Fluoroquinolones; Humans; Pneumonia

1994
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
    British journal of clinical pharmacology, 1996, Volume: 41, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxacin; Cohort Studies; Drug Prescriptions; Female; Humans; Male; Middle Aged; Norfloxacin; Ofloxacin; Pregnancy; Product Surveillance, Postmarketing; Treatment Outcome

1996
Antibiotic therapy for Salmonella enteritis.
    Journal of paediatrics and child health, 1999, Volume: 35, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Child; Child, Preschool; Enteritis; Humans; Infant; Salmonella Infections

1999
Palatability of oral antibiotics among children in an urban primary care center.
    Archives of pediatrics & adolescent medicine, 2000, Volume: 154, Issue:3

    Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Cefixime; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Flavoring Agents; Humans; Male; Pain Measurement; Patient Acceptance of Health Care; Taste; Urban Population

2000
Data on HIV infection in women expands.
    Positive living (Los Angeles, Calif.), 1999, Volume: 8, Issue:10

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Sexually Transmitted Diseases; Viral Load

1999
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae

2001
Expedited treatment for partners of patients with gonorrhea and/or chlamydial infection: impact on rates of persistence or recurrence.
    Postgraduate medicine, 2005, Volume: 117, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Chlamydia Infections; Drug Therapy, Combination; Female; Gonorrhea; Humans; Male; Randomized Controlled Trials as Topic; Secondary Prevention; Sex Education; Sexual Partners

2005
Pelvic inflammatory disease in adolescents: care delivery in pediatric ambulatory settings.
    Pediatric emergency care, 2005, Volume: 21, Issue:7

    Topics: Academic Medical Centers; Adolescent; Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Cefixime; Doxycycline; Drug Utilization Review; Emergency Service, Hospital; Female; Humans; Insurance, Health; Maryland; Outcome and Process Assessment, Health Care; Outpatient Clinics, Hospital; Patient Discharge; Patient Education as Topic; Pediatrics; Pelvic Inflammatory Disease; Practice Guidelines as Topic; Retrospective Studies; Sexually Transmitted Diseases

2005
School-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae among Philadelphia public high school students.
    Sexually transmitted diseases, 2006, Volume: 33, Issue:10

    Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Child; Chlamydia Infections; Chlamydia trachomatis; DNA, Bacterial; Female; Gonorrhea; Health Knowledge, Attitudes, Practice; Humans; Male; Mass Screening; Neisseria gonorrhoeae; Philadelphia; Prevalence; Reagent Kits, Diagnostic; Schools; Students

2006
In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2006, Volume: 12, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Drug Synergism; Humans; Male; Neisseria gonorrhoeae

2006
Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2006, Volume: 12, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Humans; Male; Neisseria gonorrhoeae

2006
In vitro induction of resistance by tissue concentrations of azithromycin, clarithromycin, cefixime and amoxicillin/clavulanate in clinical isolates of Streptococcus pyogenes.
    Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:4

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefixime; Cells, Cultured; Clarithromycin; Drug Resistance, Bacterial; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Streptococcus pyogenes

2006
[Variability in antibiotic prescription in the pediatric population of Castile and Leon (Spain) from 2001 to 2005 in relation to urban or rural setting].
    Anales de pediatria (Barcelona, Spain : 2003), 2007, Volume: 67, Issue:2

    Topics: Age Factors; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefixime; Child; Drug Prescriptions; Humans; Models, Theoretical; Primary Health Care; Rural Population; Spain; Urban Population

2007
Pharyngeal gonorrhoea - is dual therapy the way forward?
    International journal of STD & AIDS, 2007, Volume: 18, Issue:9

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Chlamydia Infections; Doxycycline; Drug Therapy, Combination; Female; Gonorrhea; Humans; Male; Medical Audit; Metronidazole; Pharyngeal Diseases; Retrospective Studies

2007
Diagnosis and treatment of urethritis in men.
    American family physician, 2010, Apr-01, Volume: 81, Issue:7

    Topics: Adolescent; Adult; Azithromycin; Black or African American; Cefixime; Ceftriaxone; Chlamydia Infections; Chlamydia trachomatis; Contact Tracing; Doxycycline; Drug Therapy, Combination; Gonorrhea; HIV Infections; Humans; Male; Mycoplasma Infections; Ureaplasma Infections; Urethritis; White People; Young Adult

2010
Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2011, Apr-07, Volume: 16, Issue:14

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Drug Resistance, Multiple, Bacterial; England; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sexual Partners; Treatment Failure; Young Adult

2011
Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
    MMWR. Morbidity and mortality weekly report, 2012, Aug-10, Volume: 61, Issue:31

    Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Centers for Disease Control and Prevention, U.S.; Doxycycline; Drug Administration Schedule; Drug Resistance, Microbial; Female; Gonorrhea; Humans; Injections, Intramuscular; Male; Neisseria gonorrhoeae; United States

2012
Combination therapy for gonorrhoea: in vitro synergy testing.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:3

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Synergism; Gentamicins; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; United Kingdom

2013
Multiplex bead suspension array for screening Neisseria gonorrhoeae antibiotic resistance genetic determinants in noncultured clinical samples.
    The Journal of molecular diagnostics : JMD, 2013, Volume: 15, Issue:1

    Topics: Alleles; Anti-Infective Agents; Azithromycin; Cefixime; Cephalosporins; Chromosomes, Bacterial; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillins; Plasmids; Reproducibility of Results; Sensitivity and Specificity; Sequence Analysis, DNA; Spectinomycin; Tetracycline

2013
Update on Emerging Infections: news from the Centers for Disease Control and Prevention. Update to the CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections .
    Annals of emergency medicine, 2013, Volume: 61, Issue:1

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Doxycycline; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae

2013
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11

    Topics: Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; beta-Lactam Resistance; Cefixime; Ceftriaxone; Ciprofloxacin; Epidemiological Monitoring; Female; Gonorrhea; Humans; Incidence; Japan; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Penicillin G

2013
Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.
    Sexually transmitted diseases, 2013, Volume: 40, Issue:9

    Topics: Alberta; Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gonorrhea; Heterosexuality; Homosexuality, Female; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Phylogeny; Retrospective Studies

2013
Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada.
    Sexually transmitted diseases, 2013, Volume: 40, Issue:11

    Topics: Adult; Alberta; Anti-Bacterial Agents; Azithromycin; Cefixime; Drug Therapy, Combination; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharyngeal Diseases; Pharynx; Retrospective Studies; Sexual Behavior; Treatment Failure

2013
Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
    BMC infectious diseases, 2013, Dec-26, Volume: 13

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Switzerland; Young Adult

2013
Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally.
    Sexually transmitted infections, 2014, Volume: 90, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; DNA, Bacterial; Female; Gonorrhea; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Neisseria gonorrhoeae; Penicillins; Saskatchewan; Sequence Analysis, DNA; Spectinomycin; Tetracycline; Young Adult

2014
Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.
    BMC infectious diseases, 2014, Feb-25, Volume: 14

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Phenotype; Switzerland; Tetracycline; Young Adult

2014
Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:8

    Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Japan; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Promoter Regions, Genetic; Repressor Proteins; RNA, Ribosomal, 23S; Spectinomycin; Treatment Failure

2014
Changing antimicrobial resistance profiles among Neisseria gonorrhoeae isolates in Italy, 2003 to 2012.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ciprofloxacin; Humans; Italy; Male; Neisseria gonorrhoeae; Penicillinase; Penicillins; Retrospective Studies; Tetracycline

2014
Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2014, Nov-13, Volume: 19, Issue:45

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Europe; European Union; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance

2014
Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe.
    Sexually transmitted diseases, 2014, Volume: 41, Issue:12

    Topics: Adult; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Microbial; Europe; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Risk Factors; Sentinel Surveillance

2014
The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:5

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Population Surveillance; Urethritis; Young Adult

2015
High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9

    Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Humans; Isoxazoles; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds

2015
Gonococcal Conjunctivitis Despite Successful Treatment of Male Urethritis Syndrome.
    Sexually transmitted diseases, 2016, Volume: 43, Issue:2

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Conjunctivitis; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Urethritis

2016
Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary.
    Annals of clinical microbiology and antimicrobials, 2016, Sep-20, Volume: 15, Issue:1

    Topics: Adult; Alleles; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gene Expression; Gonorrhea; Humans; Hungary; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Phylogeny; Porins; Prevalence; Spectinomycin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetracycline; Transferrin-Binding Protein B

2016
WGS to predict antibiotic MICs for Neisseria gonorrhoeae.
    The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7

    Topics: Anti-Bacterial Agents; Azithromycin; Canada; Cefixime; Ciprofloxacin; Drug Resistance, Bacterial; England; Genome, Bacterial; Gonorrhea; High-Throughput Nucleotide Sequencing; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin G; Tetracycline; United States; Whole Genome Sequencing

2017
A new rapid resazurin-based microdilution assay for antimicrobial susceptibility testing of Neisseria gonorrhoeae.
    The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Fluorescence; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Oxazines; Xanthenes

2017
Antimicrobial susceptibility in
    Sexually transmitted infections, 2018, Volume: 94, Issue:1

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult; Zimbabwe

2018
Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
    BMC infectious diseases, 2017, 09-11, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Female; Gonorrhea; Heterosexuality; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult

2017
High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003-15): time to consider point-of-care or molecular testing for precision treatment?
    The Journal of antimicrobial chemotherapy, 2018, Jan-01, Volume: 73, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Point-of-Care Systems; Retrospective Studies; Saskatchewan; Spectinomycin; Young Adult

2018
Accuracy and reproducibility of the Etest to detect drug-resistant Neisseria gonorrhoeae to contemporary treatment.
    Journal of medical microbiology, 2018, Volume: 67, Issue:1

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Reproducibility of Results

2018
Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    BMC infectious diseases, 2018, 01-17, Volume: 18, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cervix Uteri; Ciprofloxacin; Female; Germany; Gonorrhea; Humans; Laboratories; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins; Rectum; Urethra; Vagina; Young Adult

2018
Prescription and non-prescription antibiotic dispensing practices in part I and part II pharmacies in Moshi Municipality, Kilimanjaro Region in Tanzania: A simulated clients approach.
    PloS one, 2018, Volume: 13, Issue:11

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Community Pharmacy Services; Cross-Sectional Studies; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Pharmacists; Surveys and Questionnaires; Tanzania

2018
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    BMC infectious diseases, 2018, Dec-03, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Diagnostic Tests, Routine; Drug Resistance, Bacterial; Europe; Female; Gentamicins; Gonorrhea; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Spectinomycin; Young Adult

2018
Six penA Codons Accurately and Reliably Predict Cefixime-Decreased Susceptibility in Neisseria gonorrhoeae.
    The Journal of infectious diseases, 2020, 02-18, Volume: 221, Issue:5

    Topics: Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Codon; Evolution, Molecular; Gonorrhea; Humans; Neisseria gonorrhoeae; United States

2020
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
    BMC infectious diseases, 2019, Dec-10, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ciprofloxacin; Drug Resistance, Bacterial; European Union; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae

2019
Outbreak of acute undifferentiated febrile illness in Kathmandu, Nepal: clinical and epidemiological investigation.
    BMC infectious diseases, 2020, Jan-30, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Child; Disease Outbreaks; Female; Fever; Humans; Male; Middle Aged; Nepal; Ofloxacin; Risk Factors; Typhoid Fever; Virus Diseases; Young Adult

2020
Altered gut microbiota by azithromycin attenuates airway inflammation in allergic asthma.
    The Journal of allergy and clinical immunology, 2020, Volume: 145, Issue:5

    Topics: Allergens; Animals; Anti-Bacterial Agents; Asthma; Azithromycin; Bronchoalveolar Lavage Fluid; Cefixime; Cytokines; Fecal Microbiota Transplantation; Feces; Female; Gastrointestinal Microbiome; Mice, Inbred BALB C; Ovalbumin; Th2 Cells

2020
First Case of High-Level Azithromycin-Resistant Neisseria gonorrhoeae in North Carolina.
    Sexually transmitted diseases, 2020, Volume: 47, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; HIV Seronegativity; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; North Carolina; Penicillins; Pharynx; Tetracycline; Whole Genome Sequencing

2020
External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany.
    BMC infectious diseases, 2020, Jul-16, Volume: 20, Issue:1

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Germany; Gonorrhea; Humans; Laboratories; Laboratory Proficiency Testing; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Quality Control; Reference Standards; Surveys and Questionnaires

2020
Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
    BMC infectious diseases, 2021, Mar-18, Volume: 21, Issue:1

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; European Union; Female; Gonorrhea; Heterosexuality; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sex Factors; Sexual and Gender Minorities; Sexual Behavior

2021
Tracking Antimicrobial Resistance in Neisseria gonorrhoeae from the Molecular Level Using Endocervical Swabs.
    Laboratory medicine, 2022, Jan-06, Volume: 53, Issue:1

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pregnancy; Spectinomycin

2022
Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand.
    Scientific reports, 2021, 11-04, Volume: 11, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gonorrhea; Heterosexuality; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Docking Simulation; Neisseria gonorrhoeae; Thailand

2021
Gentamicin Susceptibility in Neisseria gonorrhoeae and Treatment Outcomes for Urogenital Gonorrhea After 25 Years of Sustained Gentamicin Use in Malawi.
    Sexually transmitted diseases, 2022, 04-01, Volume: 49, Issue:4

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Female; Gentamicins; Gonorrhea; Humans; Malawi; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Polymorphism, Single Nucleotide; Spectinomycin; Tetracycline; Treatment Outcome

2022
Markedly Increasing Antibiotic Resistance and Dual Treatment of Neisseria gonorrhoeae Isolates in Guangdong, China, from 2013 to 2020.
    Antimicrobial agents and chemotherapy, 2022, 04-19, Volume: 66, Issue:4

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; China; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae

2022
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study.
    The Lancet. Microbe, 2021, Volume: 2, Issue:11

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Neisseria gonorrhoeae; World Health Organization

2021
Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study.
    The Lancet. Microbe, 2022, Volume: 3, Issue:6

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Europe; Genomics; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sexual and Gender Minorities

2022
Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    BMC infectious diseases, 2022, Jun-07, Volume: 22, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharyngitis; Sexual and Gender Minorities

2022
Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates From Peru, 2018 and 2019.
    Sexually transmitted diseases, 2022, 10-01, Volume: 49, Issue:10

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Peru; Spectinomycin

2022
Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand.
    PloS one, 2022, Volume: 17, Issue:7

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Sequence Analysis; Spectinomycin; Tetracycline; Thailand

2022
Multicentre Clinical Evaluation of a Molecular Diagnostic Assay to Identify Neisseria gonorrhoeae Infection and Detect Antimicrobial Resistance.
    International journal of antimicrobial agents, 2023, Volume: 61, Issue:5

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pathology, Molecular

2023
Frequency and Antibiotics Sensitivity Pattern of Culture-Positive Salmonella Typhi in Children.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2023, Volume: 33, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever

2023
Emergence of a predominant sequence type ST7363 and the increasing trend of resistance to cefixime and ceftriaxone in Neisseria gonorrhoeae in Southern Taiwan, 2019-2021.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2023, Volume: 56, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Taiwan

2023
Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.
    BMC infectious diseases, 2023, Apr-20, Volume: 23, Issue:1

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sexual and Gender Minorities

2023
Antimicrobial Resistance Profiling and Genome Analysis of the penA-60.001 Neisseria gonorrhoeae Clinical Isolates in China in 2021.
    The Journal of infectious diseases, 2023, 09-15, Volume: 228, Issue:6

    Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae

2023
Correlates of
    BMJ open, 2023, 08-04, Volume: 13, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gonorrhea; HIV Infections; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quebec; Sentinel Surveillance; Sexual and Gender Minorities

2023
The third nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2016-2017.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:11

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Gonorrhea; Humans; Japan; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Spectinomycin; Urethritis

2023
Use of genome sequencing to resolve differences in gradient diffusion and agar dilution antimicrobial susceptibility testing performance of
    Journal of clinical microbiology, 2023, Nov-21, Volume: 61, Issue:11

    Topics: Agar; Alberta; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Retrospective Studies; Tetracycline

2023
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Neisseria gonorrhoeae; Ontario; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sequence Analysis, DNA

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013